OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dupilumab Safety and Efficacy up to 1 Year in Children Aged 6 Months to 5 Years with Atopic Dermatitis: Results from a Phase 3 Open-Label Extension Study
Amy S. Paller, Elaine C. Siegfried, Eric L. Simpson, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 4, pp. 655-668
Open Access | Times Cited: 13
Amy S. Paller, Elaine C. Siegfried, Eric L. Simpson, et al.
American Journal of Clinical Dermatology (2024) Vol. 25, Iss. 4, pp. 655-668
Open Access | Times Cited: 13
Showing 13 citing articles:
The Association of Inflammatory Indexes Derived from Peripheral Blood Cell Count and Clinical Signs with Response to Treatment with Dupilumab in Pediatric Patients with Moderate-to-Severe Atopic Dermatitis
Lingzhao Zhang, Jiangshan Pi, Jinsong Wang, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 271-282
Open Access | Times Cited: 1
Lingzhao Zhang, Jiangshan Pi, Jinsong Wang, et al.
Journal of Inflammation Research (2025) Vol. Volume 18, pp. 271-282
Open Access | Times Cited: 1
RECENT DEVELOPMENTS AND ADVANCES IN ATOPIC DERMATITIS: FOCUS ON EPIDEMIOLOGY, PATHOPHYSIOLOGY AND TREATMENT IN THE CONTEXT
A. Toledo, Maria Isabel de Brito Theodoro, Isabela Marangoni Cremonezi, et al.
International Journal of Health Science (2025) Vol. 5, Iss. 4, pp. 1-6
Closed Access
A. Toledo, Maria Isabel de Brito Theodoro, Isabela Marangoni Cremonezi, et al.
International Journal of Health Science (2025) Vol. 5, Iss. 4, pp. 1-6
Closed Access
Rubinstein–Taybi Syndrome With Severe Eczema, Recurrent Infections, and Hyper IgE Profile Responsive to Dupilumab Treatment
Arti Nanda, Maysoun Al Rushood, Waguih W. Tawfeek, et al.
Pediatric Dermatology (2025)
Closed Access
Arti Nanda, Maysoun Al Rushood, Waguih W. Tawfeek, et al.
Pediatric Dermatology (2025)
Closed Access
Adverse Effects of Dupilumab in a Child with Atopic Dermatitis: A Case Report of Anaphylaxis and Literature Review
Jing Zhang, Zhouxian Pan, Shuang Zhao, et al.
Allergy medicine. (2025), pp. 100035-100035
Open Access
Jing Zhang, Zhouxian Pan, Shuang Zhao, et al.
Allergy medicine. (2025), pp. 100035-100035
Open Access
Emerging treatments for dermatologic diseases in infants, children, and adolescents: a systematic review of clinical trials on biologics and small molecule inhibitors
Alireza Jafarzadeh, Elham Behrangi, Mina Khosravi, et al.
Inflammopharmacology (2025) Vol. 33, Iss. 4, pp. 1617-1672
Closed Access
Alireza Jafarzadeh, Elham Behrangi, Mina Khosravi, et al.
Inflammopharmacology (2025) Vol. 33, Iss. 4, pp. 1617-1672
Closed Access
Dupilumab‐Associated Ocular Surface Disease in Paediatric Atopic Dermatitis Patients: Results From the BioDay Registry
Lisa P. van der Rijst, Chantal M. van Luijk, Susan van der Kamp, et al.
Clinical & Experimental Allergy (2025)
Open Access
Lisa P. van der Rijst, Chantal M. van Luijk, Susan van der Kamp, et al.
Clinical & Experimental Allergy (2025)
Open Access
Modern Possibilities of Usage Dupilumab in Children
Anna A. Kosova, Anastasiya V. Fayans, Aishan Е. Ibaduiiaeva, et al.
Педиатрическая фармакология (2025) Vol. 21, Iss. 6, pp. 520-533
Open Access
Anna A. Kosova, Anastasiya V. Fayans, Aishan Е. Ibaduiiaeva, et al.
Педиатрическая фармакология (2025) Vol. 21, Iss. 6, pp. 520-533
Open Access
Comparative efficacy of biologics and small molecule drugs in treating pediatric atopic dermatitis in patients aged 2–18 years: A 12–16 week network meta‐analysis of randomized controlled trials
Su‐Boon Yong, Berne Ting, Ikbal Andrian Malau, et al.
Pediatric Allergy and Immunology (2025) Vol. 36, Iss. 2
Closed Access
Su‐Boon Yong, Berne Ting, Ikbal Andrian Malau, et al.
Pediatric Allergy and Immunology (2025) Vol. 36, Iss. 2
Closed Access
Evaluation of dupilumab on the disease burden in children and adolescents with atopic dermatitis: A population‐based cohort study
Serena Yun‐Chen Tsai, Jonathan M. Gaffin, Elena B. Hawryluk, et al.
Allergy (2024) Vol. 79, Iss. 10, pp. 2748-2758
Closed Access | Times Cited: 3
Serena Yun‐Chen Tsai, Jonathan M. Gaffin, Elena B. Hawryluk, et al.
Allergy (2024) Vol. 79, Iss. 10, pp. 2748-2758
Closed Access | Times Cited: 3
New Opportunities of Dupilumab in Achieving Disease Control in Preschool Age Patients with Atopic Dermatitis: Clinical Case
Julia Levina, Polina A. Pyzhyanova, Vera G. Kalugina, et al.
Педиатрическая фармакология (2024) Vol. 21, Iss. 4, pp. 361-368
Open Access
Julia Levina, Polina A. Pyzhyanova, Vera G. Kalugina, et al.
Педиатрическая фармакология (2024) Vol. 21, Iss. 4, pp. 361-368
Open Access
ABCs of Biologics in Pediatric Eczema: An Updated Review on the Safety and Efficacy of Systemic Treatments for Pediatric Atopic Dermatitis and Future Directions
Sarah Kamsiah Zemlok, JiaDe Yu
Current Dermatology Reports (2024)
Closed Access
Sarah Kamsiah Zemlok, JiaDe Yu
Current Dermatology Reports (2024)
Closed Access
Low Infection Rates With Long‐Term Dupilumab Treatment in Patients Aged 6 Months to 5 Years: An Open‐Label Extension Study
Amy S. Paller, Michele Ramien, Michael J. Cork, et al.
Pediatric Dermatology (2024)
Open Access
Amy S. Paller, Michele Ramien, Michael J. Cork, et al.
Pediatric Dermatology (2024)
Open Access
Quoi de neuf en dermatologie pédiatrique ?
S. Mallet
Annales de Dermatologie et de Vénéréologie - FMC (2024) Vol. 4, Iss. 8, pp. 8S27-8S35
Closed Access
S. Mallet
Annales de Dermatologie et de Vénéréologie - FMC (2024) Vol. 4, Iss. 8, pp. 8S27-8S35
Closed Access
